Advances in the pharmacologic treatment of bipolar depression

scientific article

Advances in the pharmacologic treatment of bipolar depression is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0006-3223(02)01741-9
P8608Fatcat IDrelease_kxqmes4q6jfv3gsnb2kf54jcui
P698PubMed publication ID12706953

P50authorSusan L McElroyQ56816544
Paul E. KeckQ111738411
P2093author name stringErik B Nelson
P2860cites workMoclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trialQ28208895
A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar DisorderQ29394100
Effectiveness and safety of long-term antidepressant treatment in bipolar disorderQ30999313
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.Q33844681
Historical perspectives and natural history of bipolar disorderQ33920209
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disordersQ33927263
Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?Q33942947
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depressionQ33949128
Bipolar depression: pharmacotherapy and related therapeutic strategiesQ34052825
Unitary or binary nature of classification of depressive illness and its implications for the scope of manic depressive disorderQ34211850
New perspectives in the acute treatment of bipolar depression.Q35073842
Indicators of suicide over 10 years in a specialist mood disorders unit sample.Q40667500
A novel augmentation strategy for treating resistant major depressionQ43514882
Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patientsQ43540822
Antidepressant-induced mania in bipolar patients: identification of risk factors.Q43622365
Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depressionQ43761132
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapyQ43846648
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersQ43931805
Olanzapine versus divalproex in the treatment of acute maniaQ44013092
Bipolar depression and antidepressant-induced mania: a naturalistic study.Q44136511
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorderQ44403599
Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study.Q51960801
Antidepressant-Associated Mania and Psychosis Resulting in Psychiatric AdmissionsQ56209637
The nature of bipolar depression: implications for the definition of melancholiaQ57244721
Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combinationQ70504944
Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depressionQ73317622
The treatment of bipolar depressionQ73617031
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectbipolar depressionQ56014658
P304page(s)671-679
P577publication date2003-04-01
P1433published inBiological PsychiatryQ4914961
P1476titleAdvances in the pharmacologic treatment of bipolar depression
P478volume53

Reverse relations

cites work (P2860)
Q36424640A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression
Q35111584Acceleration and augmentation strategies for treating bipolar depression
Q46055786Adjunctive aripiprazole in bipolar I depression
Q36624146Antidepressants and suicidal behavior in bipolar disorder
Q44727578Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine
Q45272320Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder
Q42257957Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test
Q83200405Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers
Q46200033Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression
Q64126908Pramipexole: augmentation in the treatment of depressive symptoms
Q24643545Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder
Q35164720The combination of olanzapine and fluoxetine in mood disorders
Q35936247Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence
Q82351280Treatment-resistant bipolar disorder
Q79351262[Monitoring mood regulating drugs in bipolar disorder]